A G protein–coupled receptor (GPCR) is encoded within the genome of Kaposi's sarcoma– associated herpesvirus (KSHV)/human herpesvirus 8, a virus that may be involved in the pathogenesis of Kaposi's sarcoma and primary effusion lymphomas. KSHV-GPCR exhibits constitutive signaling activity that causes oncogenic transformation. We report that human interferon (IFN)-γ–inducible protein 10 (HuIP-10), a C-X-C chemokine, specifically inhibits signaling of KSHV-GPCR. In contrast, monokine induced by IFN-γ (HuMig), which like HuIP-10 is an agonist of C-X-C chemokine receptor 3, does not inhibit KSHV-GPCR signaling. Moreover, HuIP-10, but not HuMig, inhibits KSHV-GPCR–induced proliferation of NIH 3T3 cells. These results show that HuIP-10 is an inverse agonist that converts KSHV-GPCR from an active to an inactive state. Thus, a human chemokine inhibits constitutive signaling and cellular proliferation that is mediated by a receptor encoded by a human disease-associated herpesvirus.
Skip Nav Destination
Article navigation
20 July 1998
Brief Definitive Report|
July 20 1998
Human Interferon-γ–inducible Protein 10 (IP-10) Inhibits Constitutive Signaling of Kaposi's Sarcoma–associated Herpesvirus G Protein–coupled Receptor
Elizabeth Geras-Raaka,
Elizabeth Geras-Raaka
From the *Division of Molecular Medicine, Department of Medicine, Cornell University Medical College and The New York Hospital, New York 10021; and the ‡Biomedical Research Centre, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada
Search for other works by this author on:
Anjali Varma,
Anjali Varma
From the *Division of Molecular Medicine, Department of Medicine, Cornell University Medical College and The New York Hospital, New York 10021; and the ‡Biomedical Research Centre, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada
Search for other works by this author on:
Hao Ho,
Hao Ho
From the *Division of Molecular Medicine, Department of Medicine, Cornell University Medical College and The New York Hospital, New York 10021; and the ‡Biomedical Research Centre, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada
Search for other works by this author on:
Ian Clark-Lewis,
Ian Clark-Lewis
From the *Division of Molecular Medicine, Department of Medicine, Cornell University Medical College and The New York Hospital, New York 10021; and the ‡Biomedical Research Centre, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada
Search for other works by this author on:
Marvin C. Gershengorn
Marvin C. Gershengorn
From the *Division of Molecular Medicine, Department of Medicine, Cornell University Medical College and The New York Hospital, New York 10021; and the ‡Biomedical Research Centre, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada
Search for other works by this author on:
Elizabeth Geras-Raaka
From the *Division of Molecular Medicine, Department of Medicine, Cornell University Medical College and The New York Hospital, New York 10021; and the ‡Biomedical Research Centre, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada
Anjali Varma
From the *Division of Molecular Medicine, Department of Medicine, Cornell University Medical College and The New York Hospital, New York 10021; and the ‡Biomedical Research Centre, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada
Hao Ho
From the *Division of Molecular Medicine, Department of Medicine, Cornell University Medical College and The New York Hospital, New York 10021; and the ‡Biomedical Research Centre, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada
Ian Clark-Lewis
From the *Division of Molecular Medicine, Department of Medicine, Cornell University Medical College and The New York Hospital, New York 10021; and the ‡Biomedical Research Centre, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada
Marvin C. Gershengorn
From the *Division of Molecular Medicine, Department of Medicine, Cornell University Medical College and The New York Hospital, New York 10021; and the ‡Biomedical Research Centre, University of British Columbia, Vancouver V6T 1Z4, British Columbia, Canada
Address correspondence to Marvin C. Gershengorn, Cornell University Medical College, 1300 York Ave., Rm. A328, New York, NY 10021. Phone: 212-746-6275; Fax: 212-746-6289; E-mail: [email protected]
Received:
December 19 1997
Revision Received:
April 17 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 188 (2): 405–408.
Article history
Received:
December 19 1997
Revision Received:
April 17 1998
Citation
Elizabeth Geras-Raaka, Anjali Varma, Hao Ho, Ian Clark-Lewis, Marvin C. Gershengorn; Human Interferon-γ–inducible Protein 10 (IP-10) Inhibits Constitutive Signaling of Kaposi's Sarcoma–associated Herpesvirus G Protein–coupled Receptor . J Exp Med 20 July 1998; 188 (2): 405–408. doi: https://doi.org/10.1084/jem.188.2.405
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement